A Dose Study of Doxil in a Dose Dense, 14 Day CDOP/Rituximab Regimen for Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma (NHL)> 60 Years or With Compromised Cardiac Status.

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2006 by The Alvin and Lois Lapidus Cancer Institute.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Ortho Biotech Products, L.P.
Information provided by:
The Alvin and Lois Lapidus Cancer Institute
ClinicalTrials.gov Identifier:
NCT00333008
First received: May 31, 2006
Last updated: September 25, 2006
Last verified: September 2006
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given